Product Details
Synonyms
IAP
Source
Cynomolgus ALPI Protein, His Tag (ALI-C52H3) is expressed from human 293 cells (HEK293). It contains AA Ile 20 - Thr 501 (Accession # A0A2K5VFX3).
Predicted N-terminus: Ile 20
Request for sequenceMolecular Characterization

Other Tags and Version Biotin & Other Labeled Version
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 54 kDa. The protein migrates as 65-80 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
The protein is designed as a dimer.
Endotoxin
Less than 1.0 EU per μg by the LAL method / rFC method.
Purity
>95% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
Formulation
Supplied as 0.2 μm filtered solution in 20 mM Tris, 150 mM NaCl, Glycerol, pH7.5 with trehalose as protectant.
Contact us for customized product form or formulation.
Shipping
This product is supplied and shipped with dry ice, please inquire the shipping cost.
Storage
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- The product MUST be stored at -70°C or lower upon receipt;
- -70°C for 3 months under sterile conditions.
ACRO Quality Management System
Customers Also Viewed
Performance Data
SDS-PAGE

Cynomolgus ALPI Protein, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).
SEC-MALS

The purity of Cynomolgus ALPI Protein, His Tag (Cat. No. ALI-C52H3) is more than 90% and the molecular weight of this protein is around 115-140 kDa verified by SEC-MALS.
Report
Bioactivity-ELISA

Immobilized Cynomolgus ALPI Protein, His Tag (Cat. No. ALI-C52H3) at 5 μg/mL (100 μL/well) can bind various dilution ratio of Anti-ALPP/ALPG/ALPI Polyclonal Antibody (QC tested).
Protocol
Customer Reviews Writing Reviews

Background
Recent Advances
- English Name:
Intestinal alkaline phosphatase
- Category:
- Approved Drugs:
0 Details
- Drugs in Clinical Trials:
1 Details
- Highest Development Stage:
Phase 1 Clinical



















